Prihlásiť sa Zaregistrujte sa zadarmo

Príjmy spoločnosti Novo Nordisk A/S

Aká je hodnota metriky Príjmy spoločnosti Novo Nordisk A/S?

Hodnota metriky Príjmy spoločnosti Novo Nordisk A/S je kr52.825B

Aká je definícia metriky Príjmy?

Výsledok príjmov pre kmeňových akcionárov (Income) sa rovná celkovému príjmu mínus vyplatené prioritné dividendy.

Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.

Príjmy spoločností v sektore Health Care sektor na OTC v porovnaní so spoločnosťou Novo Nordisk A/S

Čomu sa venuje spoločnosť Novo Nordisk A/S?

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Firmy s metrikou príjmy podobnou spoločnosti Novo Nordisk A/S